Cell membrane-anchored and tumor-targeted IL-12 (attIL12)-T cell therapy for eliminating large and heterogeneous solid tumors

J Immunother Cancer. 2022 Jan;10(1):e003633. doi: 10.1136/jitc-2021-003633.

Abstract

Background: Adoptive T-cell transfer has become an attractive therapeutic approach for hematological malignancies but shows poor activity against large and heterogeneous solid tumors. Interleukin-12 (IL-12) exhibits potent antitumor efficacy against solid tumors, but its clinical application has been stalled because of toxicity. Here, we aimed to develop a safe approach to IL-12 T-cell therapy for eliminating large solid tumors.

Methods: We generated a cell membrane-anchored IL-12 (aIL12), a tumor-targeted IL-12 (ttIL12), and a cell membrane-anchored and ttIL-12 (attIL12) and a cell membrane-anchored and tumor-targeted ttIL-12 (attIL12) armed T cells, chimeric antigen receptor-T cells, and T cell receptor-T (TCR-T) cells with each. We compared the safety and efficacy of these armed T cells in treating osteosarcoma patient-derived xenograft tumors and mouse melanoma tumors after intravenous infusions of the armed T cells.

Results: attIL12-T cell infusion showed remarkable antitumor efficacy in human and mouse large solid tumor models. Mechanistically, attIL12-T cells targeted tumor cells expressing cell-surface vimentin, enriching effector T cell and interferon γ production in tumors, which in turn stimulates dendritic cell maturation for activating secondary T-cell responses and tumor antigen spreading. Both attIL12- and aIL12-T-cell transfer eliminated peripheral cytokine release and the associated toxic effects.

Conclusions: This novel approach sheds light on the safe application of IL-12-based T-cell therapy for large and heterogeneous solid tumors.

Keywords: costimulatory and Inhibitory T-cell receptors; cytokines; dendritic cells; immunotherapy; lymphocytes; tumor-infiltrating.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Cell- and Tissue-Based Therapy / methods*
  • Disease Models, Animal
  • Humans
  • Immunotherapy / methods*
  • Interleukin-12 / immunology*
  • Mice
  • Neoplasms / immunology*
  • Receptors, Antigen, T-Cell / metabolism*

Substances

  • Receptors, Antigen, T-Cell
  • Interleukin-12